Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients

被引:123
作者
Zanardini, R
Gazzoli, A
Ventriglia, M
Perez, J
Bignotti, S
Rossini, PM
Gennarelli, M
Bocchio-Chiavetto, L
机构
[1] IRCCS San Giovanni Dio Fatebenefratelli, Genet Unit, I-25123 Brescia, Italy
[2] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, I-25121 Brescia, Italy
[3] Isola Tiberina, S Giovanni Calibita FBF, AFaR Dept Neurosci, Rome, Italy
关键词
depression; BDNF; rTMS; serum; drug-resistant; HDRS;
D O I
10.1016/j.jad.2005.12.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Depression has been associated with low brain-derived neurotrophic factor (BDNF) serum levels, while antidepressant drugs appear to mend this alteration. The purpose of this study was to assess BDNF serum levels in drug resistant depressed patients before and after repetitive Transcranial Magnetic Stimulation (rTMS) antidepressant treatment. Methods: BDNF levels were measured in serum of 16 resistant depressed patients using the ELISA technique. Results: BDNF baseline levels showed a negative correlation with illness severity measured by HDRS scores (R=-0.517,p=0.04) and a significant increase of serum BDNF was found after rTMS treatment (t=-2.549, df= 15, p=0.022). Conclusions: Our findings support the relationship between decreased serum BDNF and depression symptomatology and suggest a normalizing effect of rTMS antidepressant treatment. Further replications in larger samples will help to clarify the relevance of this preliminary data in the rTMS mechanism of action. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 86
页数:4
相关论文
共 25 条
  • [1] Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways
    Altar, CA
    Laeng, P
    Jurata, LW
    Brockman, JA
    Lemire, A
    Bullard, J
    Bukhman, YV
    Young, TA
    Charles, V
    Palfreyman, MG
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (11) : 2667 - 2677
  • [2] BDNF in schizophrenia, depression and corresponding animal models
    Angelucci, F
    Brenè, S
    Mathé, AA
    [J]. MOLECULAR PSYCHIATRY, 2005, 10 (04) : 345 - 352
  • [3] The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study
    Aydemir, O
    Deveci, A
    Taneli, F
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02) : 261 - 265
  • [4] Neurotrophic effects of antidepressant drugs
    Castrén, E
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (01) : 58 - 64
  • [5] Role of neurotrophic factors in the etiology and treatment of mood disorders
    Duman, RS
    [J]. NEUROMOLECULAR MEDICINE, 2004, 5 (01) : 11 - 25
  • [6] Transcranial magnetic stimulation
    George, MS
    Nahas, Z
    Lisanby, SH
    Schlaepfer, T
    Kozel, FA
    Greenberg, BD
    [J]. NEUROSURGERY CLINICS OF NORTH AMERICA, 2003, 14 (02) : 283 - +
  • [7] GONUL AS, 2005, EUR ARCH PSYCHIAT CL
  • [8] Critical role of brain-derived neurotrophic factor in mood disorders
    Hashimoto, K
    Shimizu, E
    Iyo, M
    [J]. BRAIN RESEARCH REVIEWS, 2004, 45 (02) : 104 - 114
  • [9] Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets
    Karege, F
    Schwald, M
    Cisse, M
    [J]. NEUROSCIENCE LETTERS, 2002, 328 (03) : 261 - 264
  • [10] Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity
    Karege, F
    Bondolfi, G
    Gervasoni, N
    Schwald, M
    Aubry, JM
    Bertschy, G
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (09) : 1068 - 1072